Pacs [PACS] vs Amedisys [AMED] Detailed Stock Comparison

Pacs Group Inc.

NYSE
Loading...

Amedisys Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pacs Group Inc. wins in 9 metrics, Amedisys Inc. wins in 11 metrics, with 0 ties. Amedisys Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Pacs Group Inc. Amedisys Inc. Better
P/E Ratio (TTM) 28.73 39.30 Pacs Group Inc.
Price-to-Book Ratio 5.80 2.69 Amedisys Inc.
Debt-to-Equity Ratio 377.77 35.34 Amedisys Inc.
PEG Ratio 14.85 -2.78 Pacs Group Inc.
EV/EBITDA 24.41 13.74 Amedisys Inc.
Profit Margin (TTM) 3.62% 3.56% Pacs Group Inc.
Operating Margin (TTM) 6.97% 11.70% Amedisys Inc.
EBITDA Margin (TTM) 6.97% 11.70% Amedisys Inc.
Return on Equity 22.96% 6.67% Pacs Group Inc.
Return on Assets (TTM) 3.57% 6.52% Amedisys Inc.
Free Cash Flow (TTM) $155.07M $214.29M Amedisys Inc.
1-Year Return 251.55% 2.68% Pacs Group Inc.
Price-to-Sales Ratio (TTM) 1.04 1.38 Pacs Group Inc.
Enterprise Value $8.92B $3.48B Pacs Group Inc.
EV/Revenue Ratio 1.69 1.45 Amedisys Inc.
Gross Profit Margin (TTM) 16.46% 43.96% Amedisys Inc.
Revenue per Share (TTM) $34 $73 Amedisys Inc.
Earnings per Share (Diluted) $1.22 $2.57 Amedisys Inc.
Beta (Stock Volatility) 0.06 0.90 Pacs Group Inc.
Short % of Float 9.08% 9.90% Pacs Group Inc.

Pacs Group Inc. vs Amedisys Inc. Stock Performance Analysis

Loading Price Chart...

PACS
AMED

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pacs Group Inc.-0.08%3.36%-3.28%3.42%4.32%-8.25%
Amedisys Inc.0.00%0.05%3.57%7.76%10.13%10.13%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pacs Group Inc.251.55%51.17%51.17%51.17%51.17%51.17%
Amedisys Inc.2.68%-14.45%-58.43%149.36%328.29%215.59%

Performance & Financial Health Analysis: Pacs Group Inc. vs Amedisys Inc.

MetricPACSAMED
Market Information
Market Cap i$5.51B$3.32B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i796,4381,027,642
90 Day Avg. Volume i769,206618,767
Last Close$36.25$100.99
52 Week Range$7.50 - $43.08$82.15 - $101.02
% from 52W High-15.85%-0.03%
All-Time High$43.92 (Oct 28, 2024)$325.12 (Jan 25, 2021)
% from All-Time High-17.46%-68.94%
Growth Metrics
Quarterly Revenue Growth0.12%0.05%
Quarterly Earnings Growth0.61%-0.13%
Financial Health
Profit Margin (TTM) i0.04%0.04%
Operating Margin (TTM) i0.07%0.12%
Return on Equity (TTM) i0.23%0.07%
Debt to Equity (MRQ) i377.7735.34
Cash & Liquidity
Book Value per Share (MRQ)$6.05$37.48
Cash per Share (MRQ)$1.25$10.26
Operating Cash Flow (TTM) i$404.22M$239.42M
Levered Free Cash Flow (TTM) i$241.90M$300.69M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Pacs Group Inc. vs Amedisys Inc.

MetricPACS (Apr 24, 2026)AMED (Aug 31, 2025)
Price Ratios
P/E Ratio (TTM) i28.7339.30
Forward P/E i14.8519.76
PEG Ratio i14.85-2.78
Price to Sales (TTM) i1.041.38
Price to Book (MRQ) i5.802.69
Market Capitalization
Market Capitalization i$5.51B$3.32B
Enterprise Value i$8.92B$3.48B
Enterprise Value Metrics
Enterprise to Revenue i1.691.45
Enterprise to EBITDA i24.4113.74
Risk & Other Metrics
Beta i0.060.90
Book Value per Share (MRQ) i$6.05$37.48

Financial Statements Comparison: Pacs Group Inc. vs Amedisys Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPACS (2025)AMED (2024)
Revenue/Sales i5.29B2.35B
Cost of Goods Sold i4.51B1.33B
COGS % of Revenue i85.2%56.7%
Gross Profit i780.33M1.02B
Gross Margin i14.8%43.3%
Research & Development iN/AN/A
Operating Income (EBIT) i309.60M209.57M
Operating Margin i5.9%8.9%
EBITDA i368.48M292.47M
EBITDA Margin i7.0%12.5%
Pre-Tax Income i284.45M86.22M
Pre-Tax Income % of Revenue i5.4%3.7%
Income Tax i92.99M48.05M
Income Tax % of Revenue i1.8%2.0%
Net Income (Profit) i191.46M38.16M
Profit Margin i3.6%1.6%

Balance Sheet & Liquidity Metrics

MetricPACS (2025)AMED (2024)
Cash & Equivalents i197.02M303.24M
Total Current Assets i1.07B632.08M
Total Current Assets % of Revenue i20.2%26.9%
Total Current Liabilities i1.00B514.39M
Total Current Liabilities % of Revenue i18.9%21.9%
Long-Term Debt i3.28B395.42M
Long-Term Debt % of Revenue i62.1%16.8%
Total Shareholders Equity i952.45M1.18B
Retained Earnings i309.58M791.16M
Retained Earnings % of Revenue i5.9%33.7%
Property, Plant & Equipment i3.12B167.80M

Cash Flow Statement Comparison

MetricPACS (2025)AMED (2024)
Operating Cash Flow i343.04M144.50M
Operating Cash Flow % of Revenue i6.5%6.2%
Capital Expenditures i-249.16M-6.55M
Free Cash Flow i155.07M214.29M
FCF Margin i2.9%9.1%
Debt Repayment i-60.22M0
Common Stock Repurchase iN/A-6.15M

Short Interest & Institutional Ownership Analysis

MetricPACSAMED
Shares Short i4.25M3.20M
Short Ratio i5.366.84
Short % of Float i9.08%9.90%
Shares Outstanding i156.62M32.78M
Float Shares i46.23M32.24M
% Held by Insiders i71.24%1.95%
% Held by Institutions i29.28%96.37%
% Held by Public i-0.52%1.68%

Dividend Analysis & Yield Comparison: Pacs Group Inc. vs Amedisys Inc.

MetricPACSAMED
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A